A combination of fibrosis and inflammation one year after kidney transplantation is associated with reduced graft function and graft survival, according to an online report in the Journal of the American Society of Nephrology.
In a study of 151 recipients of living-donor kidneys, Mark D. Steagall, MD, and co-investigators found that those with both fibrosis and inflammation had a decline in glomerular filtration rate and reduced graft survival as well as a rejection-like gene expression signature. Patients with normal histology or fibrosis alone had stable kidney function between one and five years.
“Early interventions aimed at altering rejection-like inflammation may improve long-term survival of kidney allografts,” the authors concluded.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.